Information  X 
Enter a valid email address
  Print      Mail a friend       More announcements

Monday 08 January, 2018

CELIXIR Plc

CELIXIR: CTA approval for potentially pivotal HeartcelTM Phase IIb trial

YASTEST

a d v e r t i s e m e n t